Improving Efficiency in Stroke Prevention

  • Views:

    Views Icon 4477
  • Likes:

    Heart Icon 13


LAA closure (LAAC) is a proven alternative to oral anticoagulation for preventing stroke in patients with non-valvular AF.

Please join this webinar at 6pm CEST / 5pm BST on LAAC Patient Management in the COVID-19 Era to reinforce the importance to treat LAA closure patients, overcome barriers during a pandemic and optimizing an elective procedure with the new LAA closure device WATCHMAN FLX.




Performed By:

David Hildick-Smith

David Hildick-Smith

Tim Betts

Tim Betts

Moderated By:

A John Camm

A John Camm

This webinar is supported by:


Rationale for an alternative to DOAC in stroke prevention – J. Camm

- Limitations of lifelong DOAC therapy
- High bleeding risk and special subgroups

Case presentation – FLX with early discharge – D. Hildick-Smith

- Clinical history
- CT scan – anatomic considerations

Current state of LAAC with a new generation device – T. Betts


Case conclusion – D. Hildick-Smith

- Implantation technique
- Imaging guidance selection / anesthesia (GA vs. sedation)
- Post-procedure antithrombotic therapy

Panel Discussion and Conclusion

Learning Objectives

  • Discuss the emerging evidence for the LAA closure therapy in the era of NOACs.
  • Share experience about the management of elective procedures during the pandemic to offer treatment for patients at high risk for stroke.
  • Learn how new imaging modalities (ICE, mini-micro TEE, CT) and workstreams could reduce the need for General Anesthesia, streamlining the LAAC procedure and the patient follow-up.
  • Learn about the latest LAAC clinical data and the proven safety profile of WATCHMAN FLX.
  • Understand how the new implantation technique of WATCHMAN FLX can optimize procedural results.


  • Interventional Cardiologists
  • Electrophysiologists

Faculty Biographies

David Hildick-Smith

David Hildick-Smith

David Hildick-Smith is a Professor of Interventional Cardiology and Consultant Cardiologist at the Sussex Cardiac Centre. He is Director of the Cardiac Research, ex-Treasurer of the British Cardiovascular Interventions Society, and has more than 15 years experience of Interventional Cardiology.

View full profile
Tim Betts

Tim Betts

John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, UK

Professor Betts is a Consultant in Cardiology and Cardiac Electrophysiology at the Oxford Private Heart and Lung Centre at Nuffield Health Oxford, The Manor Hospital. He also works at the Oxford University Hospitals NHS Trust.

View full profile
A John Camm

A John Camm

Professor John Camm became Professor of Clinical Cardiology at St. George’s University of London 1986. He continues to hold this positions alongside positions as Professor of Clinical Cardiology at St George’s Hospital London and Professor of Cardiology at Imperial College London.

An internationally renowned expert in atrial fibrillation (AF), Prof Camm leads the European Network for translational research in atrial fibrillation, which works towards a better understanding of AF. Other research interests include ventricular tachycardia, cardiomyopathy, pacemakers and sudden cardiac death.

Professor Camm is a Senior Consulting Editor for the European Heart Journal and Editor of the European Society of Cardiology Textbook of Cardiovascular Medicine. He has received numerous awards for his contributions to cardiology, including the British Cardiovascular Society Mackenzie Medal and the European Society of Cardiology Gold Medal.

View full profile